Correction: Effectiveness of educational interventions for healthcare workers on vaccination dialogue with older adults: a systematic review.

Autor: Wennekes MD; Centre for Infectious Disease Control, National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands. manuela.wennekes@rivm.nl.; Athena Institute, VU University Amsterdam, Amsterdam, The Netherlands. manuela.wennekes@rivm.nl., Almási T; Syreon Research Institute, Budapest, Hungary., Eilers R; Centre for Infectious Disease Control, National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands., Mezei F; Syreon Research Institute, Budapest, Hungary., Petykó ZI; Syreon Research Institute, Budapest, Hungary.; Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary., Timen A; Centre for Infectious Disease Control, National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands.; Athena Institute, VU University Amsterdam, Amsterdam, The Netherlands.; Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands., Vokó Z; Syreon Research Institute, Budapest, Hungary.; Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary.

Publikováno v: Archives of public health = Archives belges de sante publique [Arch Public Health] 2024 Apr 11; Vol. 82 (1), pp. 47. Date of Electronic Publication: 2024 Apr 11.

Recommendations for patient involvement in health technology assessment in Central and Eastern European countries.

Autor: Jakab I; Syreon Research Institute, Budapest, Hungary.; Patient advocate, Budapest, Hungary., Dimitrova M; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Houÿez F; European Organisation for Rare Diseases (EURORDIS), Paris, France., Bereczky T; Patvocates GmbH, Riemerling, Germany., Fövényes M; Lymfoma Slovensko, Bratislava, Slovakia., Maravic Z; Digestive Cancers Europe, Brussels, Belgium., Belina I; Coalition of Associations in Healthcare, Zagreb, Croatia., Andriciuc C; Romanian Federation of Diabetes Associations, Cluj Napoca, Romania., Tóth K; Syreon Research Institute, Budapest, Hungary.; Bridge of Health Alliance against Breast Cancer Association, Budapest, Hungary., Piniazhko O; Health Technology Assessment Department of State Expert Centre, Ministry of Health of Ukraine, Kyiv, Ukraine., Hren R; Syreon Research Institute, Budapest, Hungary.; Faculty of Mathematics and Physics, University of Ljubljana, Ljubljana, Slovenia., Gutierrez-Ibarluzea I; Basque Foundation for Health Innovation and Research, Landa, Spain., Czech M; Head of Pharmacoeconomic Department, Institute of Mother and Child, Warsaw, Poland., Tesar T; Department of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University, Bratislava, Slovakia., Niewada M; Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland., Lorenzovici L; Syreon Research Romania, Tirgu Mures, Romania.; Department of Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science, and Technology, Targu Mures, Romania., Kamusheva M; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Manova M; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.; National Council on Prices and Reimbursement of Medicines, Sofia, Bulgaria., Savova A; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.; National Council on Prices and Reimbursement of Medicines, Sofia, Bulgaria., Mitkova Z; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Tachkov K; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Németh B; Syreon Research Institute, Budapest, Hungary., Petykó ZI; Syreon Research Institute, Budapest, Hungary.; Centre for Health Technology Assessment, Semmelweis University, Budapest, Hungary., Dawoud D; Science, Policy and Research Programme, National Institute for Health and Care Excellence, London, United Kingdom., Delnoij D; National Health Care Institute (ZIN), Diemen, Netherlands., Knies S; National Health Care Institute (ZIN), Diemen, Netherlands., Goettsch W; National Health Care Institute (ZIN), Diemen, Netherlands.; WHO Collaborating Centre for Pharmaceutical Policy and Regulation, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, Netherlands., Kaló Z; Syreon Research Institute, Budapest, Hungary.; Centre for Health Technology Assessment, Semmelweis University, Budapest, Hungary.

Publikováno v: Frontiers in public health [Front Public Health] 2023 Jul 03; Vol. 11, pp. 1176200. Date of Electronic Publication: 2023 Jul 03 (Print Publication: 2023).

Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making.

Autor: Németh B; Syreon Research Institute, Budapest, HU 1142, Hungary., Kamusheva M; Department of Organization & Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BG 1000, Bulgaria., Mitkova Z; Department of Organization & Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BG 1000, Bulgaria., Petykó ZI; Syreon Research Institute, Budapest, HU 1142, Hungary., Zemplényi A; Syreon Research Institute, Budapest, HU 1142, Hungary.; Center for Health Technology Assessment & Pharmacoeconomics Research, Faculty of Pharmacy, University of Pécs, Pécs, Hungary., Dimitrova M; Department of Organization & Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BG 1000, Bulgaria., Tachkov K; Department of Organization & Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BG 1000, Bulgaria., Balkányi L; Medical Informatics R&D Center, Pannon University, Veszprém, HU 8200, Hungary., Czech M; Department of Pharmacoeconomics, Institute of Mother & Child, Warsaw, PL 01-211, Poland., Dawoud D; Science Policy & Research Programme, Science Evidence & Analytics Directorate, National Institute for Health & Care Excellence (NICE), London, United Kingdom.; Cairo University, Faculty of Pharmacy, Cairo, Egypt., Goettsch W; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.; National Health Care Institute, Diemen, NL 1120 AH, The Netherlands., Hren R; Faculty of Mathematics & Physics, University of Ljubljana, Ljubljana, Slovenia., Knies S; National Health Care Institute, Diemen, NL 1120 AH, The Netherlands., Lorenzovici L; Syreon Research Romania, Tirgu Mures, RO 540004, Romania.; G. E. Palade University of Medicine, Pharmacy, Science & Technology, Tirgu Mures, RO 540142, Romania., Maravic Z; Digestive Cancers Europe, Brussels, BE 1040, Belgium., Piniazhko O; HTA Department of State Expert Centre of the Ministry of Health of Ukraine, Kyiv, Ukraine., Zerovnik S; Ministry of Health, Ljubljana, Slovenia., Kaló Z; Syreon Research Institute, Budapest, HU 1142, Hungary.; Centre for Health Technology Assessment, Semmelweis University, Budapest, HU 1091 Hungary.

Publikováno v: Journal of comparative effectiveness research [J Comp Eff Res] 2023 Apr; Vol. 12 (4), pp. e220157. Date of Electronic Publication: 2023 Mar 02.

Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives.

Autor: Kaló Z; Center for Health Technology Assessment, Semmelweis University, Üllői rd. 25, 1085, Budapest, Hungary.; Pharmaceutical Policy Research, Syreon Research Institute, Mexikói str. 65/A, 1142, Budapest, Hungary., Petykó ZI; Center for Health Technology Assessment, Semmelweis University, Üllői rd. 25, 1085, Budapest, Hungary.; Pharmaceutical Policy Research, Syreon Research Institute, Mexikói str. 65/A, 1142, Budapest, Hungary., Fricke FU; Technische Hochschule Nürnberg, Nürnberg, Germany., Maniadakis N; Department of Public Health Policies, Sector of Health Systems and Policy, School of Public Health, University of West Attica, Athens, Greece., Tesař T; Department of Organisation and Management of Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, Bratislava, Slovakia., Podrazilová K; Association of Health Insurance Companies, Prague, Czech Republic., Espin J; Andalusian School of Public Health, Granada, Spain., Inotai A; Center for Health Technology Assessment, Semmelweis University, Üllői rd. 25, 1085, Budapest, Hungary. andras.inotai@syreon.eu.; Pharmaceutical Policy Research, Syreon Research Institute, Mexikói str. 65/A, 1142, Budapest, Hungary. andras.inotai@syreon.eu.

Publikováno v: Cost effectiveness and resource allocation : C/E [Cost Eff Resour Alloc] 2021 Jul 15; Vol. 19 (1), pp. 42. Date of Electronic Publication: 2021 Jul 15.